CHRONIC NEUROSTEROID TREATMENT DECREASES THE EFFICACY OF BENZODIAZEPINE LIGANDS AND NEUROSTEROIDS AT THE GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR COMPLEX IN MAMMALIAN CORTICAL-NEURONS

Authors
Citation
R. Yu et Mk. Ticku, CHRONIC NEUROSTEROID TREATMENT DECREASES THE EFFICACY OF BENZODIAZEPINE LIGANDS AND NEUROSTEROIDS AT THE GAMMA-AMINOBUTYRIC ACID(A) RECEPTOR COMPLEX IN MAMMALIAN CORTICAL-NEURONS, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 784-789
Citations number
32
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00223565
Volume
275
Issue
2
Year of publication
1995
Pages
784 - 789
Database
ISI
SICI code
0022-3565(1995)275:2<784:CNTDTE>2.0.ZU;2-O
Abstract
The effect of chronic 5 alpha-pregnane-3 alpha-ol-20-one (5 alpha 3 al pha; neurosteroid) treatment was investigated on the gamma-aminobutyri c acid (GABA), 5 alpha 3 alpha, and ligands that bind to the benzodiaz epine (BZ) site on GABA-induced [Cl-36(-)]influx in intact cultured ma mmalian cortical neurons. Chronic 5 alpha 3 alpha treatment (1 mu M; 5 days) decreased the efficacy of GABA, because its E(max) (maximal res ponse) value was decreased, whereas the EC(50) (potency) value was not altered. Chronic 5 alpha 3 alpha treatment also decreased the E(max) value of BZ agonists like diazepam to potentiate GABA-induced [Cl-36(- )] influx, and decreased the -E(max) (maximal inhibitory response) val ue of inverse agonists like ,7-dimelhoxy-4-ethyl-beta-carboline-3'-car boxylate to inhibit GABA-induced [Cl-36(-)] influx, whereas not alteri ng their EC(50)/IC50 values. Furthermore, chronic 5 alpha 3 alpha trea tment decreased the E(max) value of 5 alpha 3 alpha to potentiate GABA -induced [Cl-36(-)] influx, without altering its EC(50) value. The dec reased efficacy of GABA and 5 alpha 3 alpha were reversed by concomita nt exposure of the neurons to R5135 (3 alpha-hydroxy-16-imino-5 beta-1 7-androstan-11-one; a competitive GABA antagonist). Taken together, th ese findings suggest that chronic 5 alpha 3 alpha treatment produces d ecreased efficacy of GABA, ligands that bind to the BZ site, and neuro steroids at the GABA(A)-BZ receptor complex. The decreased efficacy is heterologous in nature and involves mediation via the GABA(A) recepto r site.